Skip to main content
Top
Published in: Critical Care 1/2020

Open Access 01-12-2020 | ECMO | Editorial

How I approach membrane lung dysfunction in patients receiving ECMO

Authors: Bishoy Zakhary, Leen Vercaemst, Phillip Mason, Marta V. Antonini, Roberto Lorusso, Daniel Brodie

Published in: Critical Care | Issue 1/2020

Login to get access

Excerpt

With improvements in circuit technology and expanding supportive evidence, extracorporeal membrane oxygenation (ECMO) use has grown rapidly over the past decade [1]. Advances in pump and membrane lung (ML) design have led to simpler and more efficient circuits. Circuit-related complications, however, remain frequent and associated with considerable morbidity [2]. …
Appendix
Available only for authorised users
Literature
1.
go back to reference Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322(6):557–68.CrossRef Brodie D, Slutsky AS, Combes A. Extracorporeal life support for adults with respiratory failure and related indications: a review. JAMA. 2019;322(6):557–68.CrossRef
3.
go back to reference Dornia C, Philipp A, Bauer S, Lubnow M, Muller T, Lehle K, et al. Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography. ASAIO J. 2014;60(6):652–6.CrossRef Dornia C, Philipp A, Bauer S, Lubnow M, Muller T, Lehle K, et al. Analysis of thrombotic deposits in extracorporeal membrane oxygenators by multidetector computed tomography. ASAIO J. 2014;60(6):652–6.CrossRef
4.
go back to reference Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352.CrossRef Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352.CrossRef
5.
go back to reference Maul TM, Massicotte MP, Wearden PD. ECMO biocompatibility: surface coatings, anticoagulation, and coagulation monitoring. In: Firstenberg MS, editor. Extracorporeal Membrane Oxygenation: Advances in Therapy. Croatia: IntechOpen; 2016. p. 30–5. Maul TM, Massicotte MP, Wearden PD. ECMO biocompatibility: surface coatings, anticoagulation, and coagulation monitoring. In: Firstenberg MS, editor. Extracorporeal Membrane Oxygenation: Advances in Therapy. Croatia: IntechOpen; 2016. p. 30–5.
6.
go back to reference Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T, et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange–retrospective analysis of 265 cases. PLoS ONE. 2014;9(12):e112316.CrossRef Lubnow M, Philipp A, Foltan M, Bull Enger T, Lunz D, Bein T, et al. Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange–retrospective analysis of 265 cases. PLoS ONE. 2014;9(12):e112316.CrossRef
7.
go back to reference Hastings SM, Deshpande SR, Wagoner S, Maher K, Ku DN. Thrombosis in centrifugal pumps: location and composition in clinical and in vitro circuits. Int J Artif Organs. 2016;39(4):200–4.CrossRef Hastings SM, Deshpande SR, Wagoner S, Maher K, Ku DN. Thrombosis in centrifugal pumps: location and composition in clinical and in vitro circuits. Int J Artif Organs. 2016;39(4):200–4.CrossRef
8.
go back to reference Lehle K, Philipp A, Gleich O, Holzamer A, Muller T, Bein T, et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54(6):612–7.CrossRef Lehle K, Philipp A, Gleich O, Holzamer A, Muller T, Bein T, et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J. 2008;54(6):612–7.CrossRef
9.
go back to reference Epis F, Belliato M. Oxygenator performance and artificial-native lung interaction. J Thorac Dis. 2018;10(Suppl 5):S596–605.CrossRef Epis F, Belliato M. Oxygenator performance and artificial-native lung interaction. J Thorac Dis. 2018;10(Suppl 5):S596–605.CrossRef
10.
go back to reference Zakhary B, Sheldrake J, Pellegrino V. Extracorporeal membrane oxygenation and V/Q ratios: an ex vivo analysis of CO2 clearance within the Maquet Quadrox-iD oxygenator. Perfusion. 2020;35(1):29–33.CrossRef Zakhary B, Sheldrake J, Pellegrino V. Extracorporeal membrane oxygenation and V/Q ratios: an ex vivo analysis of CO2 clearance within the Maquet Quadrox-iD oxygenator. Perfusion. 2020;35(1):29–33.CrossRef
Metadata
Title
How I approach membrane lung dysfunction in patients receiving ECMO
Authors
Bishoy Zakhary
Leen Vercaemst
Phillip Mason
Marta V. Antonini
Roberto Lorusso
Daniel Brodie
Publication date
01-12-2020
Publisher
BioMed Central
Keywords
ECMO
ECMO
Published in
Critical Care / Issue 1/2020
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-020-03388-2

Other articles of this Issue 1/2020

Critical Care 1/2020 Go to the issue